Peptide MedixCJC-1295 DAC + Ipamorelin
CJC-1295 DAC + Ipamorelin
10 mg· 10 mg· ≥99% by HPLC per component purity· vial
Albumin-binding GHRH analogue co-lyophilized with a selective GHS-R1a agonist
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
Vendor price
USD 110.00
unknown
About this product
This vial co-lyophilizes two growth-hormone secretagogues at a 1:1 mass ratio: CJC-1295 with DAC, a modified GRF(1-29) analogue carrying a drug affinity complex, and ipamorelin, a selective pentapeptide agonist at the growth hormone secretagogue receptor. The pairing is a classic experimental design in somatotroph pharmacology because the two peptides act on different receptors. The DAC modification — a maleimidopropionyl group that forms a covalent bond with cysteine-34 of circulating albumin — extends the analogue's residence time dramatically compared with the unconjugated version.
Specifications
- Peptide
- CJC-1295 DAC + Ipamorelin
- Strength
- 10 mg
- Package
- 10 mg
- Purity
- ≥99% by HPLC per component
- Form
- vial
More from Peptide Medix
Other products in catalog
Research-use only. Not for human or veterinary use. MyDosage does not sell or ship this product — purchases happen directly with Peptide Medix.